Wynik wyszukiwania w bazie Polska Bibliografia Lekarska GBL

Zapytanie: CHROŚCIŃSKA
Liczba odnalezionych rekordów: 1



Przejście do opcji zmiany formatu | Wyświetlenie wyników w wersji do druku
1/1

Tytuł oryginału: Neuroprotective effects of an antiepileptic drugs.
Autorzy: Trojnar Michał K., Małek Robert, Chrościńska Magdalena, Nowak Stanisław, Błaszczyk Barbara, Czuczwar Stanisław J.
Źródło: Pol. J. Pharmacol. 2002: 54 (6) s.557-566, tab., bibliogr. 70 poz.
Sygnatura GBL: 313,156

Hasła klasyfikacyjne GBL:
  • farmacja
  • neurologia

    Typ dokumentu:
  • tytuł obcojęzyczny

    Wskaźnik treści:
  • ludzie
  • zwierzęta
  • króliki
  • myszy
  • szczury
  • in vitro

    Streszczenie angielskie: Experimental and clinical data indicate that epilepsy and seizures lead to neuronal cell loss and irreversible brain damage. This neurodegeneration results not only in the central nervous system dysfunction but may also be responsible for the decreased efficacy of some antiepileptic drugs (AEDs). The aim of this review was to assemble current literature dat on neuroprotective properties of AEDs. The list of hypothetical neuroprotectants is long and consists of substances which act via different mechanisms. We focus on AEDs since this heterogenous group of pharmaceuticals, as far as mechanisms of their action and mechanisms of neuronal death are concerned should provide protection in addition to antiseizure effect itself. Most studies on neuroprotection are based on animal experimental models of neuronal degeneration. Electrically and pharmacologically evoked seizures as well as different models of ischemia are frequently used. Algtough our knowledge about properties of AEDs is still not complete and discrepancies ocassionally occur, the group seems to be promising in terms of neuroprotection. Some of the drugs, though, turn out to be neutral or even have adverse effects on the central nervous system, especially on immature brain tissue (barbiturates and benzodiazepines). Unfortunatelly, we cannot fully extrapolate animal data to humans, therefore further well designed clinical trials are necessary to determine neuroprotective properties of AEDs in humans. However, there is a hope that AEDs will have potential to severe as neuroprotectants not only in seizures, but...

    stosując format: